523031 — ADS Diagnostic Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for ADS Diagnostic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 106 | 104 | 138 | 241 | 161 |
| Cost of Revenue | |||||
| Gross Profit | 51.6 | 59.8 | 70.4 | 120 | 91.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 96.2 | 93.8 | 129 | 210 | 147 |
| Operating Profit | 10 | 10.3 | 8.91 | 30.7 | 13.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.42 | 5.64 | 4.86 | 25 | 10.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.37 | 4.4 | 4.06 | 18.5 | 8.05 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.37 | 4.4 | 4.06 | 18.5 | 8.05 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.37 | 4.4 | 4.06 | 18.5 | 8.05 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.53 | 1.86 | 5.11 | 8.44 | 3.67 |
| Dividends per Share |